INR 20.96
(-4.86%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -785.00 INR | -210.29% |
2022 | 2139.00 INR | 349.59% |
2021 | -857.00 INR | -10.88% |
2020 | -772.94 INR | 24.72% |
2019 | -1026.77 INR | 37.13% |
2018 | -1633.19 INR | -85.35% |
2017 | -881.12 INR | 55.1% |
2016 | -1962.34 INR | -32.56% |
2015 | -1480.38 INR | -28.1% |
2014 | -1155.60 INR | -73.94% |
2013 | -664.36 INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -717.00 INR | 43.45% |
2023 Q4 | -1268.00 INR | -267.54% |
2023 FY | -2359.00 INR | -210.29% |
2023 Q1 | -259.00 INR | -110.15% |
2023 Q3 | -345.00 INR | 29.01% |
2023 Q2 | -486.00 INR | -87.64% |
2022 FY | 2139.00 INR | 349.59% |
2022 Q1 | -48.00 INR | 77.14% |
2022 Q3 | -162.00 INR | 19.8% |
2022 Q2 | -202.00 INR | -320.83% |
2022 Q4 | 2552.00 INR | 1675.31% |
2021 Q3 | -218.00 INR | 11.38% |
2021 Q4 | -210.00 INR | 3.67% |
2021 Q2 | -246.00 INR | -35.16% |
2021 Q1 | -182.00 INR | -85.82% |
2021 FY | -857.00 INR | -10.88% |
2020 Q3 | -482.00 INR | -7.83% |
2020 Q1 | -46.00 INR | 79.98% |
2020 FY | -772.94 INR | 24.72% |
2020 Q4 | -97.94 INR | 79.68% |
2020 Q2 | -447.00 INR | -871.74% |
2019 Q2 | -246.00 INR | 37.4% |
2019 FY | -1026.77 INR | 37.13% |
2019 Q3 | -156.00 INR | 36.59% |
2019 Q1 | -393.00 INR | 47.75% |
2019 Q4 | -229.77 INR | -47.29% |
2018 Q2 | -205.00 INR | 43.21% |
2018 FY | -1633.19 INR | -85.35% |
2018 Q1 | -361.00 INR | -1053.08% |
2018 Q3 | -315.00 INR | -53.66% |
2018 Q4 | -752.19 INR | -138.79% |
2017 Q1 | -168.00 INR | 71.83% |
2017 Q2 | -173.00 INR | -2.98% |
2017 Q4 | 37.88 INR | 106.55% |
2017 Q3 | -578.00 INR | -234.1% |
2017 FY | -881.12 INR | 55.1% |
2016 Q2 | -464.00 INR | 13.43% |
2016 Q1 | -536.00 INR | -57.01% |
2016 FY | -1962.34 INR | -32.56% |
2016 Q4 | -596.33 INR | -62.93% |
2016 Q3 | -366.00 INR | 21.12% |
2015 Q4 | -341.38 INR | 4.11% |
2015 FY | -1480.38 INR | -28.1% |
2015 Q3 | -356.00 INR | 11.0% |
2015 Q2 | -400.00 INR | -4.44% |
2015 Q1 | -383.00 INR | 17.21% |
2014 Q2 | -321.00 INR | -64.62% |
2014 Q3 | -177.00 INR | 44.86% |
2014 Q4 | -462.60 INR | -161.36% |
2014 FY | -1155.60 INR | -73.94% |
2014 Q1 | -195.00 INR | -162.23% |
2013 Q4 | -74.36 INR | 58.46% |
2013 Q3 | -179.00 INR | -4.68% |
2013 Q2 | -171.00 INR | 0.0% |
2013 FY | -664.36 INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alfavision Overseas (India) Limited | 9.28 Million INR | 100.008% |
Biocon Limited | 50.83 Billion INR | 100.0% |
Blue Jet Healthcare Limited | 3.37 Billion INR | 100.0% |
Concord Biotech Limited | 6.26 Billion INR | 100.0% |
Dishman Carbogen Amcis Limited | -13.9 Million INR | 99.994% |
FERMENTA BIOTECH LIMITED | 1.06 Billion INR | 100.0% |
GENOMIC VALLEY BIOTECH LIMITED | 1.27 Million INR | 100.062% |
Lyka Labs Limited | 29.13 Million INR | 100.003% |
Panacea Biotec Limited | -309.7 Million INR | 100.0% |
SAMSRITA LABS LIMITED | -1.49 Million INR | 99.948% |
SMS Lifesciences India Limited | 359.47 Million INR | 100.0% |
Supriya Lifescience Limited | 1.57 Billion INR | 100.0% |
Syngene International Limited | 14.02 Billion INR | 100.0% |
TAKE Solutions Limited | -213.49 Million INR | 100.0% |
Titan Biotech Limited | 315.89 Million INR | 100.0% |
Transgene Biotek Limited | -7.08 Million INR | 99.989% |
Vanta Bioscience Limited | -31.83 Million INR | 99.998% |